UDIBI

Fecha de publicación: Septiembre 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced...

Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. VER MÁS

Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug. VER MÁS

Transferon en el 2020 VER MÁS

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS

Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....

Fecha de publicación: 20 Septiembre 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable...